Centiva Capital’s Innoviva INVA Stock Holding History

Centiva Capital’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$113K	–	1800
2023 Q1	$113K	Buy	+10,000	New	+$121K	﹤0.01%	1333

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Centiva Capital's INVA Position: Q3 2023 in Review

Centiva Capital sold out of Innoviva (INVA) in Q3 2023, closing a stake of 11,619 shares — an estimated $148K sold.

Centiva Capital first reported a position in INVA in Q3 2021 and held it in 3 quarters. The position peaked at $236K in Q3 2021. 193 funds tracked by Wall St. Rank hold INVA as of Q3 2023.

Centiva Capital reported no remaining Innoviva position as of Q3 2023 after selling out during the quarter.
Centiva Capital sold 11,619 Innoviva shares in Q3 2023, an estimated $148K.
Centiva Capital first reported a position in Innoviva in Q3 2021 and held it in 3 quarters.
Centiva Capital's Innoviva position peaked at $236K in Q3 2021.
193 funds tracked by Wall St. Rank held Innoviva as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.